您要查找的是不是：
- Objective To explore the association of CD 34 + cells and survival rate in myelodysplastic syndromes (MDS). 目的 探讨CD34+细胞与骨髓增生异常综合征 (MDS)患者生存率的相关性。
- Myelodysplastic syndromes (MDS) are a group of aquried clonal disorders of the hemopoietic stem or progenitorcell. 骨髓增生异常综合征(MDS)是一组起源于造血干细胞祖细胞的获得性克隆性疾病。
- Objective To analyse the T cell receptor (TCR) gene rearrangement in myelodysplastic syndromes (MDS). 目的为了解骨髓增生异常综合征（MDS）患者T细胞受体（TCR）基因重排情况。
- Objective To evaluate the values of immunophenotyping in the diagnosis and prognosis of myelodysplastic syndromes(MDS). 目的评价免疫表型测定在骨髓增生异常综合征(MDS)诊断及预后判断中的价值。
- Anthracycline drugs may also increase the risk of developing a secondary cancer, such as acute myelogenous leukemia or myelodysplastic syndromes. 蒽环类药物也会增加发生二次肿瘤的风险，如急性髓细胞白血病，或骨髓增生异常综合征。
- Aguayo A,Kantarjian H,Manshouri T,et al.Angiogenesis in acute and chronic leukemias and myelodysplastic syndromes [J].Blood,2000,96 (6):2240. 陶艳玲;邹典定.;血管内皮生长因子在急性白血病患者中表达的研究[J]
- Procarbazine, nitrogen mustard, and ifosfamide, which can increase risk for myelodysplastic syndromes and acute myelogenous leukemia. 丙卡巴肼、氮芥和异环磷酰胺：可增加患骨髓增生异常综合症和急性粒细胞白血病的风险。
- Title： Application of interphase fluorescen ce in situ hybridization to detect the f requence of trisomy 8 in myelodysplastic syndromes. 关键词：骨髓增生异常综合征；荧光原位杂交；间期；染色体8号；细；胞遗传学
- A related blood disorder, myelodysplastic syndromes, or MDS, occurs when the bone marrow begins producing poorly functioning or immature blood cells. 骨髓增生异常综合症（MDS）也是一种血液相关的疾病，是由于骨髓产生非成熟或无功能的血细胞。
- Treatment for leukemia, lymphoma, myeloma, myelodysplastic syndromes or other blood cancers usually includes chemotherapy and/or other drug therapies. 白血病、淋巴瘤、骨髓瘤、骨髓增生异常综合征或其他血癌的治疗通常包括了化疗和（或）其他药物疗法。
- Myelodysplastic Syndromes are a group of conditions that cause insufficient production of blood cells, which is often lethal. 骨髓增生异常综合征是一组条件不足，造成生产的血细胞，这往往是致命的。
- Objective:The comparison between the clinical practicability of the FAB classification and the WHO classification of Myelodysplastic syndromes (MDS) was analyzed and assessed. 目的:评价和分析骨髓增生异常综合征(MDS)从FAB分型到WHO分型的发展和临床意义。
- Poluru LR, Sana ZR, Samia S, et al. High percentage of patients with myelodysplastic syndromes(MDS) show mitochondrial DNA (mt-DNA) mutations. Blood. 2000, 96(suppl):1551. 顾红兵.;骨髓增生异常综合征患者血清铁蛋白含量测定
- Myelodysplastic syndromes are refered to as a group of diseases characterized by abnormal clonal proliferation of hematopoietic stem cells with pancytopenia and dysplasia. 摘要骨髓增生异常综合徵是以造血干细胞的异常克隆性增生、血细胞减少、骨髓出现病态造血为特徵的一类疾病。
- DNA repair enzyme inhibitors , which are derived from toxins found in certain plants, can cause acute myelogenous leukemia and myelodysplastic syndromes. DNA修复酶抑制剂，取自某些植物的毒素，可导致急性髓细胞白血病和骨髓增生异常综合征。
- Neutrophilic granulocytopenia concomitant with myelodysplastic syndrome. 骨髓异常增生综合症伴发的中性粒细胞减少症。
- Objective To discuss from the clinical and cytogenetic aspect that part of patients now diagnosed as myelodysplastic syndromes (MDS) could be diagnosed early as leukemia and be classified as subacute myeloid leukemia(Sub-AML). 目的从临床和细胞遗传学的角度分析骨髓增生异常综合征(MDS)中部分病例是否可更早的诊断为白血病,并探讨亚急性髓性白血病(SubAML)作为白血病一种类型的可能性。
- Objective To evaluate the value of interphase fluorescence in situ hybridization(FISH) in the detection of acquired complete and partial deletion of chromosome 5(-5/5q-) in myelodysplastic syndromes(MDS). 目的 评价间期荧光原位杂交 (fluorescenceinsituhybridization ,FISH)在检测骨髓增生异常综合征 (MDS) - 5 / 5 q -染色体异常中的价值。
- Objective To investigate the quantity of the subset of dendritic cells(DC) and costimulatory molecule expression in peripheral blood(PB) of the patients with myelodysplastic syndromes(MDS). 目的 研究骨髓增生异常综合征(MDS)患者外周血树突状细胞(DC)及其亚群pDC和mDC的数量和比例，以及DC细胞表面协同刺激分子CD80、CD86和CD40表达，探讨树突状细胞数量、亚群和功能变化与MDS的关系。
- A related blood disorder, myelodysplastic syndromes, or MDS, occurs when the bone marrow begins producing poorly functioning or immature blood cells. About 20,000 to 30,000 new cases occur each year. 骨髓增生异常综合症（MDS）也是一种血液相关的疾病，是由于骨髓产生非成熟或无功能的血细胞。美国每年新发病例大约为20000-30000。
